MoneyWorks4Me

Lupin informs about press release

17 Nov 2023 Evaluate

Lupin has informed that it enclosed a Press release regarding receipt of US FDA approval for the Company’s Abbreviated New Drug Application for Ganirelix Acetate Injection, 250 mcg/0.5 mL Single-Dose Prefilled Syringe, to market a generic equivalent to the reference listed drug of Ganirelix Acetate Injection, 250 mcg/0.5 mL of Organon USA LLC. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1803.50
Dr. Reddys Labs. 1212.95
Cipla 1343.80
Lupin 2014.35
Zydus Lifesciences 1134.85
View more..